Author:
Li Sin-Min,Zeng Wei-Zheng,Chung Cheng-Yen,Uramaru Naoto,Huang Guan-Jhong,Wong Fung Fuh
Funder
China Medical University
National Science and Technology Council
Reference47 articles.
1. Anti-TNF-α inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events;Murdaca;Int. J. Immunopathol.,2009
2. Synthesis and pharmacological characterization of a novel nitric oxide-releasing diclofenac derivative containing a benzofuroxan moiety;de Carvalho;Eur. J. Med. Chem.,2010
3. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond;Rao;J. Pharm. Pharm. Sci.,2008
4. Role of inducible cyclooxygenase (COX-2) in inflammation;Seibert;Receptor,1994
5. S.H. Emam, A. Sonousi, E.O. Osman, D. Hwang, G.-D. Kim, R.A. Hassan, Design and synthesis of methoxyphenyl-and coumarin-based chalcone derivatives as anti-inflammatory agents by inhibition of NO production and down-regulation of NF-κB in LPS-induced RAW264. 7 macrophage cells, Bioorg. Chem., 107 (2021) 104630.